Can you contrast the mechanism of action of Slynd versus traditional combination oral contraceptives regarding venous thromboembolism risk in sedentary professionals?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you contrast the mechanism of action of Slynd versus traditional combination oral contraceptives regarding venous thromboembolism risk in sedentary professionals?
1 real search · 1 real-search pass
FDA Slynd drospirenone 4 mg prescribing information venous thromboembolism coagulation estrogen-free; CDC U.S. Medical Eligibility Criteria progestin-only pills VTE combined hormonal contraception; sedentary sitting venous thromboembolism occupational evidenceGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 1 queries…
Searches and sources
ChatGPT1 real searches · gpt-6
FDA Slynd drospirenone 4 mg prescribing information venous thromboembolism coagulation estrogen-free; CDC U.S. Medical Eligibility Criteria progestin-only pills VTE combined hormonal contraception; sedentary sitting venous thromboembolism occupational evidence Google ↗
- These highlights do not include all the information needed to use SLYND safely and effectively. See full prescribing information for SLYND. SLYND ® (drospirenone) tablets, for oral use Initial U.S. Approval: 2001 · dailymed.nlm.nih.gov
- SLYND (drospirenone) tablets, 4 mg · slynd.com
- The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease · ahajournals.org
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | Contraception · cdc.gov
- Appendices for U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 · cdc.gov
Queries
1 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA Slynd drospirenone 4 mg prescribing information venous thromboembolism coagulation estrogen-free; CDC U.S. Medical Eligibility Criteria progestin-only pills VTE combined hormonal contraception; sedentary sitting venous thromboembolism occupational evidence OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |